We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
PI Industries Limited manufactures and distributes agro chemicals in India, rest of Asia, North America, Europe, and internationally. The company offers agrochemicals, including insecticides, fungicides, and herbicides; specialty products; and generic molecules, such as profenofos, ethion, and phorate primarily under the Nominee Gold, Osheen, Biovita, Cosko, Roket, Keefun, Elite, Humesol, and Awkira brands, as well as chemical and active intermediates. It also provides research and development (R&D) services comprising target discovery, molecule design, library synthesis, lead optimization, biological evaluation, and route synthesis services; and custom synthesis and manufacturing solutions consisting of process R&D, analytical method development, synthesis of reference standards, structure elucidation and synthesis of impurities, physio-chemical studies and 5-batch analysis under GLP conditions, scale-up studies, safety data generation, waste categorization and treatability studies, process/plant engineering, and large-scale commercial production. It sells its products through distributors/dealers and retailers. The company was formerly known as Mewar Oil & General Mills Ltd. PI Industries Limited was incorporated in 1946 and is based in Gurugram, India.
TODAY'S HIGH
2689
TODAY'S LOW
2604.1
52 WEEK HIGH
3534.9
52 WEEK LOW
2333.55
% of Shares Held by
All Insider
46.97%
% of Shares Held by
Institutions
31.53%
% of Float Held by
Institutions
59.45%
Number of Institutions
Holding Shares
148
MARKET CAP
40223.88 Cr.
ETERPRISE VALUE
41191.09 Cr.
NO. OF SHARES
15.17 Cr.
BOOK VALUE
378.486
DIV. YIELD
None%
DEBT
348.09 Cr.
GROSS PROFIT
1943.30 Cr.
CASH
2371.29 Cr.
REVENUE
5101.40 Cr.
REVENUE/SHARE
337.175
Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|
Investments | 159.30 Cr. | -2015.80 Cr. | 101.40 Cr. | 26.70 Cr. |
Change To Liabilities | 117.50 Cr. | 219.70 Cr. | 31.90 Cr. | 149.80 Cr. |
Total cashflows from Investing Activities | -110.40 Cr. | -2430.40 Cr. | -984.90 Cr. | -321.60 Cr. |
Net Borrowings | -93 Cr. | -203.40 Cr. | 434.70 Cr. | -39.90 Cr. |
Total Cash from Financing Activities | -177.30 Cr. | 1690.40 Cr. | 350 Cr. | -125.10 Cr. |
Other Liabilities | -59.60 Cr. | 14.60 Cr. | 102.10 Cr. | -15.10 Cr. |
Total Assets | 0 | 1978.90 Cr. | 8 Cr. | 2.90 Cr. |
Net Income | 843.80 Cr. | 738.30 Cr. | 456.60 Cr. | 410.20 Cr. |
Change in Cash | 241 Cr. | -15 Cr. | 63.20 Cr. | -55.90 Cr. |
Effect of Exchange Rate | 0 | 0 | 0 | 0 |
Total Cash from Operating Activities | 528.70 Cr. | 725 Cr. | 698.10 Cr. | 390.80 Cr. |
Depreciation | 201.80 Cr. | 171.80 Cr. | 134.60 Cr. | 91 Cr. |
Other Cashflows from Investing Activities | 66.50 Cr. | 22.90 Cr. | 17.50 Cr. | 19.40 Cr. |
Dividends Paid | -75.80 Cr. | -60.70 Cr. | -62 Cr. | -68.90 Cr. |
Change to Inventory | -370.50 Cr. | -253.90 Cr. | -185 Cr. | -83.70 Cr. |
Change to Account Receivables | -215 Cr. | -110.70 Cr. | 76.50 Cr. | -201.30 Cr. |
Other Cashflows from Financing Activities | -8.50 Cr. | -24.40 Cr. | -30.70 Cr. | -19.20 Cr. |
Change to Net Income | 10.70 Cr. | -57.80 Cr. | 79.30 Cr. | 37.90 Cr. |
Capital Expenditures | -337.10 Cr. | -439 Cr. | -674.10 Cr. | -368.50 Cr. |
Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|
Research Development | None | None | None | None |
Effect of Accounting Charges | None | None | None | None |
Income Before Tax | 1032.80 Cr. | 938.50 Cr. | 613.80 Cr. | 537.90 Cr. |
Minority Interest | None | None | None | None |
Net Income | 940.60 Cr. | 841.30 Cr. | 581.10 Cr. | 484.70 Cr. |
Selling General Administrative | 480.40 Cr. | 459.20 Cr. | 373.40 Cr. | 328.50 Cr. |
Gross Profit | 2376.70 Cr. | 1943.30 Cr. | 1471.80 Cr. | 1250.20 Cr. |
Ebit | 940.60 Cr. | 841.30 Cr. | 581.10 Cr. | 484.70 Cr. |
Operating Income | 940.60 Cr. | 841.30 Cr. | 581.10 Cr. | 484.70 Cr. |
Other Operating Expenses | 753.90 Cr. | 468 Cr. | 380.60 Cr. | 344.30 Cr. |
Interest Expense | -12.80 Cr. | -28.10 Cr. | -16.80 Cr. | -4.70 Cr. |
Extraordinary Items | None | None | None | None |
Non Recurring | None | None | None | None |
Other Items | None | None | None | None |
Income Tax Expense | 189 Cr. | 200.20 Cr. | 157.20 Cr. | 127.70 Cr. |
Total Revenue | 5299.50 Cr. | 4577 Cr. | 3366.50 Cr. | 2840.90 Cr. |
Total Operating Expenses | 4358.90 Cr. | 3735.70 Cr. | 2785.40 Cr. | 2356.20 Cr. |
Cost of Revenue | 2922.80 Cr. | 2633.70 Cr. | 1894.70 Cr. | 1590.70 Cr. |
Total Other Income Expense Net | 92.20 Cr. | 97.20 Cr. | 32.70 Cr. | 53.20 Cr. |
Discontinued Operations | None | None | None | None |
Net Income from Continuous Ops. | 843.80 Cr. | 738.30 Cr. | 456.60 Cr. | 410.20 Cr. |
Net Income Applicable to Common Shares | 843.80 Cr. | 738.30 Cr. | 456.60 Cr. | 410.20 Cr. |
Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|
Intangible Assets | 87.40 Cr. | 72.20 Cr. | 72.50 Cr. | 34.80 Cr. |
Capital Surplus | 0 | 2199.90 Cr. | 224.90 Cr. | 205.50 Cr. |
Total Liabilities | 1670.70 Cr. | 1659.50 Cr. | 1605.70 Cr. | 869.40 Cr. |
Stock Holder Equity | 6120.40 Cr. | 5342.40 Cr. | 2619.10 Cr. | 2285.40 Cr. |
Minority Interest | 0 | 0 | 0 | 0 |
Other Liabilities | 305.70 Cr. | 264 Cr. | 279.40 Cr. | 195.70 Cr. |
Total Assets | 7791.10 Cr. | 7001.90 Cr. | 4224.80 Cr. | 3154.80 Cr. |
Common Stock | 15.20 Cr. | 15.20 Cr. | 13.80 Cr. | 13.80 Cr. |
Retained Earnings | 0 | 3102.80 Cr. | 2424.60 Cr. | 2044 Cr. |
Other Liabilities | 124.50 Cr. | 116.70 Cr. | 74 Cr. | 48 Cr. |
Good Will | 82.80 Cr. | 82.80 Cr. | 82.80 Cr. | 0 |
Treasury Stock | 6105.20 Cr. | 24.50 Cr. | -44.20 Cr. | 22.10 Cr. |
Other Assets | 215.40 Cr. | 63.90 Cr. | 72 Cr. | 78.40 Cr. |
Cash | 1410.20 Cr. | 109.60 Cr. | 124.60 Cr. | 61.40 Cr. |
Current Liabilities | 1348.20 Cr. | 1257 Cr. | 1100.50 Cr. | 811.50 Cr. |
Long Term Asset Charges | 0 | 0 | 0 | 14.10 Cr. |
Short Long Term Debt | 97.90 Cr. | 70.10 Cr. | 9.70 Cr. | 39.30 Cr. |
Other Stockholder Equity | 6105.20 Cr. | 29.60 Cr. | -35.50 Cr. | 22.10 Cr. |
Property Plant Equipment | 2396.80 Cr. | 2269.20 Cr. | 1970.90 Cr. | 1333.50 Cr. |
Total Cur. Assets | 4963.90 Cr. | 4493.10 Cr. | 2008.70 Cr. | 1690.90 Cr. |
Long Term Investments | 44.80 Cr. | 20.70 Cr. | 17.90 Cr. | 17.20 Cr. |
Net Tangible Assets | 5950.20 Cr. | 5187.40 Cr. | 2463.80 Cr. | 2250.60 Cr. |
Short Term Investments | 854.70 Cr. | 1489.50 Cr. | 7.10 Cr. | 24 Cr. |
Net Receivables | 1004.80 Cr. | 916.60 Cr. | 824.80 Cr. | 785.40 Cr. |
Long Term Debt | 169.90 Cr. | 257.40 Cr. | 399.40 Cr. | 9.90 Cr. |
Inventory | 1423.40 Cr. | 1052.80 Cr. | 798.90 Cr. | 535.70 Cr. |
Accounts Payable | 924.20 Cr. | 796 Cr. | 590.90 Cr. | 513 Cr. |